Ridgetech, Inc. (RDGT) vs Sunshine Biopharma, Inc. (SBFM)

A side-by-side comparison of Ridgetech, Inc. and Sunshine Biopharma, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

RDGT

Ridgetech, Inc.

$835994

$0.93HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

SBFM

Sunshine Biopharma, Inc.

$946332

$0.40HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — RDGT vs SBFM

growth of $100 · dividends reinvested · last 10y

RDGT -100.0% (-65.5%/yr)SBFM -100.0% (-74.0%/yr)RDGT compounded faster over this window

Log scale — wide-divergence pair

RDGT SBFM

Metrics side by side

Total return (annualized)

Metric	RDGT	SBFM
Total return (1Y)	-99.53%	N/A
Total return CAGR (3Y)	-88.79%	N/A
Total return CAGR (5Y)	-86.91%	N/A
Total return CAGR (10Y)	-67.34%	N/A

RDGT is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full RDGT analysis Full SBFM analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.